Toll Free 1-888-590-9839

  • February 6, 2019 – Modern Veterinary Therapeutics, LLC announces the U.S. launch of REVERTIDINE, the first FDA-approved generic atipamezole hydrochloride injection (5 mg/mL) for the reversal of dexmedetomidine and medetomidine in dogs. We are excited to bring one of our most successful Canadian products into the U.S. market and help our American veterinarians save more money.